3-D Matrix, Ltd. (TYO:7777)

Market Cap	56.24B
Revenue (ttm)	8.47B
Net Income (ttm)	5.00M
Shares Out	121.21M
EPS (ttm)	0.05
PE Ratio	11,248.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,371,300
Average Volume	9,127,475
Open	447.00
Previous Close	450.00
Day's Range	435.00 - 466.00
52-Week Range	102.00 - 539.00
Beta	0.25
RSI	65.99
Earnings Date	Mar 13, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.